DV
Dividend Vision

GTHP — Guided Therapeutics Inc

Guided Therapeutics Inc (GTHP)

Its deepest 1-year drawdown was 66.7%.

Guided Therapeutics is a medical technology company that develops and commercializes diagnostic devices, including LuViva, a non-invasive cervical cancer detection system. The company does not currently distribute dividends to shareholders. Guided Therapeutics appeals primarily to investors seeking exposure to medical device innovation rather than those focused on income generation.

GTHP key facts

Asset type
Stock
Asset class
Equity
Inception date
07/01/1997
Last close
$0.24
Market cap
$23,168,964
Average volume
19000.0
Payment date
03/29/2019
Beta
0.725
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.04